Alterity Therapeutics
ATHE
12 hedge funds and large institutions have $619K invested in Alterity Therapeutics in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
4% less capital invested
Capital invested by funds: $642K → $619K (-$23K)
8% less funds holding
Funds holding: 13 → 12 (-1)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$24.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$13.2K |
| 3 |
NFG
Next Financial Group
Houston,
Texas
|
+$1.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$71.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$22K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.58K |
| 4 |
Renaissance Technologies
New York
|
-$4.58K |
| 5 |
LC
Landaas & Company
Milwaukee,
Wisconsin
|
-$1K |
ATHE Hedge Fund Activity: Q3 2018 in Review
12 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2018, worth a combined $619K — down 3.6% from $642K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ATHE and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $24.8K. The largest seller was Susquehanna International Group, cutting an estimated $71.3K.
- 12 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2018, down from 13 in Q2 2018.
- Funds reported $619K of Alterity Therapeutics stock for Q3 2018, down 3.6% quarter-over-quarter.
- 1 fund opened new Alterity Therapeutics positions in Q3 2018 and 2 closed out, a net change of -1 holder.
- The largest Alterity Therapeutics buyer in Q3 2018 was Morgan Stanley, an estimated $24.8K added.
- The largest Alterity Therapeutics seller in Q3 2018 was Susquehanna International Group, an estimated $71.3K sold.
Based on aggregated 13F filings for Q3 2018.